WATERTOWN, Mass. -
June 29, 2023 -
PRLog -- What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition reaction (CuAAC reaction).
Applications of Click Chemistry
1. Sugar-mediated tumor immunity
Bertozzi, who has long been interested in sugars coated on the surface of cells, used "click chemistry" to create antibody-enzyme conjugates that reshape sugar calyces, as well as Lysosome-targeting chimera (LYTAC) that degrade membrane-bound and extracellular targets. For example, human immune cells have a class of carbohydrate-
binding receptors called SIGLEC that can bind sialoglycan. The signaling biochemistry of these receptors is almost identical to that of PD-1, the same immunosuppressive receptor, but they do not bind to PD-L1, but to sugars. Bertozzi's team developed an anti-HER2 antibody around glycans that binds to sialase, which binds to these sugars on the surface of cancer cells, allowing the immune system to recognize and attack the cancer cells.
2. Improve ADC production
In recent years, scientists have developed a new class of targeted drugs - antibody-drug conjugate (ADC) (
https://www.biochempeg.com/article/74.html). In the first generation of ADCs, the traditional coupling reaction is used, and it is not possible to control how many cytotoxic drug molecules bind to amino acid residues in monoclonal antibodies, nor is it possible to precisely control the binding position on monoclonal antibodies, which is actually a mixture of different monoclonal antibody conjugations. However, if bioorthogonal chemistry is introduced during the monoclonal antibody treatment, it provides a way to control the number and location of the coupled drug molecules. Bertozzi used a coupling technique derived from bioorthogonal chemistry, SMARTag, to pair an anti-CD22 antibody with two medenin molecules to create a new ADC drug, TRPH-222. The drug began to enter clinical trials in April 2019, and published positive results in February this year, showing good prospects for development.
Biopharma PEG offers a wide range of PEG products for click chemistry reactions (
https://www.biochempeg.com/click-chemistry). It supplies PEG products functionalized with azide, alkyne, DBCO and other cyclooctyne. Below is a part of PEG for click chemistry reactions.
DSPE-PEG-DBCO CatalogID:
11334 Purity:
≥95% CAS NO.: 2052955-83-4
DSPE-PEG-Man CatalogID:
12210 Purity:
≥95%
DOPE-PEG-FA CatalogID:
12215 Purity:
≥95%%
STA-PEG-OH CatalogID:
12266 Purity:
≥95%
N3-PEG4-OH CatalogID:
10593 Purity:
≥95% CAS NO.: 86770-67-4
N3-PEG8-NH2 CatalogID:
10615 Purity:
≥95% CAS NO.: 857891-82-8
N3-PEG12-COOH CatalogID:
10582 Purity:
≥95% CAS NO.: 1167575-20-3